Quest Diagnostics, Inc. (DGX)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SERVICES-MEDICAL LABORATORIES

500 PLAZA DRIVE SECAUCUS, NJ 07094

Quest Diagnostics is a provider of diagnostic testing, information and services. Co. is a provider of: clinical testing, which is generally is performed on whole blood, serum, plasma and other body fluids, such as urine, and specimens such as microbiology samples; and anatomic pathology services principally for the detection of cancer and are performed on tissues, such as biopsies, and other samples, such as human cells. Co.'s other operating segments include its non-clinical testing businesses and consist of its risk assessment services, clinical trials testing, healthcare information technology, and diagnostics products businesses.

Data as of 2020-09-12
Market Cap14.377 Billion Shares Outstanding134.303 Million Avg 30-day Volume1.482 Million
P/E Ratio20.1 Dividend Yield2.092 EPS5.51
Price/Sales1.909 Price cash flow ratio12.0 Price free cash flow ratio50.0
Book Value43.42 Price to Tangible Book-7.07 Alpha-0.0
Short Interest Ratio2.23 % Short Interest to Float2.1 R-squared0.462613
BETA1.28044 52-week High/Low131.81 / 73.02 Stddev0.080438
View SEC Filings from DGX instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 4 25.0% 2 (0.13%) 1 (0.06%) 100.0%
Funds Holding: 726 696 4.31% 153 (9.98%) 145 (9.27%) 5.52%
13F shares: 117.496 Million 119.237 Million -1.46% 24.007 Million 19.282 Million 24.5%
% Ownership 87.4857 89.2025 -1.92% 17.8756 14.4254 23.92%
New Positions: 125 108 15.74% 41 36 13.89%
Increased Positions 210 252 -16.67% 44 52 -15.38%
Closed Positions 86 102 -15.69% 28 27 3.7%
Reduced Positions 285 239 19.25% 53 46 15.22%
Total Calls 883.319 Thousand 912.376 Thousand -3.18% 350.2 Thousand 176.2 Thousand 98.75%
Total Puts 457.12 Thousand 699.978 Thousand -34.7% 170.1 Thousand 169.2 Thousand 0.53%
PUT/CALL Ratio 0.52 0.77 -32.47% 0.49 0.96 -48.96%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DGX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DGX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

58.4 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

58.4 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DOHERTY CATHERINE T. SVP, GROUP EXEC. CLIN. FRAN.

  • Officer
72,467 2020-09-02 5

RING TIMOTHY M

  • Director
0 2020-07-01 6

GUINAN MARK EXECUTIVE VICE PRESIDENT & CFO

  • Officer
73,579 2020-06-08 5

WILENSKY GAIL R

  • Director
29,857 2020-05-19 2

STANZIONE DANIEL

  • Director
39,572 2020-05-19 1

PFEIFFER GARY M

  • Director
21,513 2020-05-19 1

MAIN TIMOTHY L

  • Director
19,588 2020-05-19 1

GREGG VICKY B

  • Director
13,844 2020-05-19 1

TORLEY HELEN

  • Director
4,897 2020-05-19 1

MORRISON DENISE M

  • Director
3,783 2020-05-19 2

LASSITER WRIGHT III

  • Director
1,882 2020-05-19 3

DEPPE MICHAEL J VP, CORP. CONTROLLER & CAO

  • Officer
25,675 2020-05-18 5

RUSCKOWSKI STEPHEN H CHAIRMAN, CEO AND PRESIDENT

  • Officer
  • Director
237,747 2020-04-27 6

EGLINTON MANNER CARRIE SVP, ADVANCED DIAGNOSTICS

  • Officer
22,390 2020-04-27 6

DAVIS J. E. EVP, GENERAL DIAGNOSTICS

  • Officer
38,086 2020-03-16 6

PREVOZNIK MICHAEL E SVP & GENERAL COUNSEL

  • Officer
45,196 2020-03-10 6

MENDEZ MANUEL O. SVP & CHIEF COMMERCIAL OFFICER

  • Officer
29,853 2020-02-24 3

CUNNINGHAM EVERETT SVP, COMMERCIAL

  • Officer
39,032 2019-03-01 0

KLUG ROBERT A VP, CORPORATE CONTROLLER

  • Officer
6,261 2019-03-01 0

BRITELL JENNE K

  • Director
14,479 2018-06-04 0

LEIDEN JEFFREY M

  • Director
6,000 2018-05-29 0

COHEN JON R SVP & GROUP EXEC. DIAG. SOL.

  • Officer
31,757 2018-03-08 0

ZIEGLER JOHN B

  • Director
16,557 2017-02-22 0

BALDWIN JOHN C MD

  • Director
12,949 2015-08-12 0

BONGIORNO THOMAS F VP AND CORPORATE CONTROLLER

  • Officer
15,002 2015-02-27 0

HAYDON JOHN B. SVP, OPERATIONS

  • Officer
19,890 2014-02-13 0

BUEHLER WILLIAM F

  • Director
26,225 2014-02-12 0

ORDONEZ KATHY SVP, DIAGNOSTIC SOLUTIONS

  • Officer
9,569 2013-03-31 0

HAGEMANN ROBERT SVP & CHIEF FINANCIAL OFFICER

  • Officer
162,520 2013-03-05 0

MOHAPATRA SURYA N CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2012-04-30 0

MILLER JOAN ELIZABETH SVP-ONCOLOGY & NEUROLOGY SRVCS

  • Officer
90,279 2012-02-29 0

SIMMONS WAYNE R. VICE PRESIDENT, OPERATIONS

  • Officer
47,752 2011-06-16 0

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
No longer subject to file 2011-01-31 0

HAGGERTY ROSANNE

  • Director
9,334 2010-05-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2020-09-04 16:18:23 -0400 2020-09-02 M 58,392 $66.51 a 126,803 direct yes -0.3259 5.7635 5.7635 6 -0.3259 2

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2020-09-04 16:18:23 -0400 2020-09-02 S 3,776 $111.13 d 68,411 direct yes -0.3259 5.7635 5.7635 6 -0.3259 2

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2020-09-04 16:18:23 -0400 2020-09-02 S 54,616 $110.57 d 72,187 direct yes -0.3259 5.7635 5.7635 6 -0.3259 2

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2020-09-04 16:18:23 -0400 2020-09-02 M 58,392 $66.51 d 0 direct yes

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments